Skip to main content
FutureChem Co., Ltd. logo

FutureChem Co., Ltd. — Investor Relations & Filings

Ticker · 220100 ISIN · KR7220100002 KO Manufacturing
Open in API
Filings indexed 312 across all filing types
Latest filing 2020-08-04 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 220100

About FutureChem Co., Ltd.

https://www.futurechem.co.kr/?language=…

FutureChem Co., Ltd. is a company specializing in the development and production of radiopharmaceuticals for diagnostic and therapeutic applications. The company's operations cover the manufacturing of radiopharmaceutical precursors, chemical compounds, synthesis reagents, and automated synthesis modules. Its product pipeline focuses on agents for the diagnosis and treatment of various cancers and neurological disorders, including Parkinson's disease. FutureChem supports the broader radiopharmaceutical field by providing both finished products and the essential chemical building blocks and equipment required for their synthesis. The company actively establishes global partnerships for clinical supply and commercial licensing of its technologies.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)(주주배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a capital increase (share issuance) via a rights offering (주주배정 유상증자). It details the number of shares issued, the total amount raised, and the payment completion date. This falls under the category of share issuance and capital changes.
2020-08-04 Korean
증권발행실적보고서
Capital/Financing Update Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed by FutureChem with the Financial Supervisory Service (FSS) of South Korea. This document details the final results of a capital increase (rights offering), including the number of shares issued, the amount of capital raised, the use of proceeds (debt repayment and R&D), and the status of shareholding changes. This is a standard regulatory filing for capital market activities, specifically categorized under 'Capital/Financing Update' (CAP) as it reports the outcome of a financing event.
2020-08-04 Korean
전환가액의조정(제2회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from FutureChem regarding the adjustment of the conversion price for its 2nd series convertible bonds. It details the specific price change, the reason (capital increase/rights offering), and the mathematical formula used for the adjustment. This falls under capital structure changes and financing updates, specifically related to convertible securities, which is best classified as CAP (Capital/Financing Update).
2020-08-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the shareholding changes of Susung Asset Management in the company FutureChem. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes in shareholding status.
2020-08-04 Korean
권리락(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights off' (ex-rights) event due to a bonus issue (free capital increase) for the company FutureChem. It provides specific details such as the reference price and the effective date. This falls under the category of capital changes or share issues, specifically fitting the 'Share Issue/Capital Change' classification.
2020-08-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS). This type of filing is a mandatory disclosure by company insiders (directors/major shareholders) regarding their personal share transactions or changes in ownership. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2020-07-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.